New Testosterone Replacement Therapy Offers Novel Delivery System For Men With Low Testosterone NEW YORK, Oct. 27 /PRNewswire/ -- A new survey of more than 1,000 men ages 40 and older conducted by the Men's Health Network found that many experience typical symptoms of a medical condition called hypogonadism, a low level or absence of testosterone. Symptoms include diminished sexual interest, depression and changes in physical appearance. Yet nearly half of the men surveyed were not aware that hypogonadism is a medical condition, and only five percent had been diagnosed. Now, the four to five million men with hypogonadism have a new treatment option. The FDA recently approved a new and unique testosterone delivery system called Striant Testosterone Buccal System. The tablet-like product is applied to the upper gum area of the mouth where it absorbs moisture, softens, and then molds to the shape of the gum. It provides controlled and sustained release of testosterone that is absorbed directly into the bloodstream. ADDITIONAL RESOURCES: Video version and more available at http://www.prnewswire.com/broadcast/10787/10787_consumer.html Soundbites: * Christina Wang, MD, Professor of Medicine, Research and Education Institute at Harbor-UCLA Medical Center * Mort, Hypogonadism Patient VIDEO PROVIDED BY: COLUMBIA LABORATORIES DATASOURCE: Columbia Laboratories Contact: MultiVu Media Relations, +1-800-653-5313, ext. 3, for Columbia Laboratories

Copyright